Supportive care: Medicinal cannabis tick
- New England Cancer Connect
- Jul 12, 2017
- 1 min read
A Tasmanian company that has secured one of the first licences in Australia to grow cannabis and produce pain relieving drugs says it is excited to be moving into a new era. Poppy giant Tasmanian Alkaloids, with its business partner AusCann, announced to the ASX yesterday that is has been granted the licence by the Office of Drug Control to manufacture medicinal cannabis at its Westbury facility. The Hobart Mercury, 12 July 2017, page 5

Commentaires